Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients

NACompletedINTERVENTIONAL
Enrollment

416

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

August 31, 2012

Study Completion Date

December 31, 2012

Conditions
Diabetes Mellitus, Type 2Newly Diagnosed
Interventions
DRUG

exenatide injection

Patients in exenatide group will be treated with exenatide (Byetta®, Eli Lilly and Company) 5 µg BID for the first 4 weeks and then 10 µg BID thereafter.

DRUG

Mixed Protamine Zinc Recombinant Human Insulin Lispro 25R

Patients in insulin group will be treated with premixed insulin analog (Humalog Mix 25, Eli Lilly and Company). The initial insulin doses are 0.4 IU/kg per day(50% before breakfast and 50% before dinner). Insulin doses are titrated following a forced schedule according to blood glucose before breakfast and dinner.

DRUG

Pioglitazone

Patients in thiazolidinedione group will be treated with Pioglitazone 30mg daily as single dose. The dose will be increased to 45mg daily after 4 weeks.

Trial Locations (25)

100029

China-Japan Friendship Hospital, Beijing

100044

Peking University People's Hospital, Beijing

100730

Beijing Hospital, Beijing

100853

Chinese PLA General Hospital, Beijing

110001

China Medical University, Shenyang

410011

Second Xiangya Hospital of Central-south University, Changsha

510000

The Second Affiliated Hospital of Sun Yat-sen University, Guangzhou

510630

The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou

511500

Qingyuan People's hospital, Qingyuan

515041

The first Affiliated Hospital of Shantou University Medical College, Shantou

518035

Shenzhen Second People's Hospital, Shenzhen

524001

Affiliated hospital of Guangdong medical college, Zhanjiang

530000

The first affiliated hospital of Guangxi Medical College, Nanning

Unknown

Peking University First Hospital, Beijing

The Military General Hospital of Beijing PLA, Beijing

The Affiliated Hospital of Guiyang Medical College, Guiyang

The 2nd Affiliated Hospital of Harbin Medical University, Harbin

Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan

The Affiliated Hospital of Inner Mangolia Medical College, Hohhot

Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing

The First Affiliated Hospital of Nanjing Medical University, Nanjing

Zhongda Hospital of Southeast University, Nanjing

Xijing Hospital of The Fourth Military Medical University, Xi'an

The First Affiliated Hospital of Kunming Medical College, Kunming

The First Affiliated Hospital of Chongqing Medical University, Chongqing

Sponsors
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

collaborator

Amylin Pharmaceuticals, LLC.

INDUSTRY

collaborator

Ministry of Health, China

OTHER_GOV

lead

Sun Yat-sen University

OTHER